Credo director sells shares in Form 4

Credo Technology Group Holding Ltd director Sylvia Acevedo reported selling a total of 2,200 ordinary shares of CRDO on January 13, 2026.

Accepted by SEC EDGAR 01/15/2026 - 04:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Credo Technology Group Holding Ltd director Sylvia Acevedo reported selling a total of 2,200 ordinary shares of CRDO on January 13, 2026. The Form 4 shows two open-market sales of 1,100 shares each, at prices of $162.11 and $156.25 per share. After these transactions, Acevedo directly beneficially owned 18,545 ordinary shares of Credo. All reported holdings are listed as directly owned, with no derivative securities reported.

Insider Trade Summary

Net Seller: 2,200 shares

Net Sell 2 txns

Insider ACEVEDO SYLVIA

Role Director

Sold 2,200 shs ($350K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,100	$162.11	$178K
Sale	Ordinary Shares	1,100	$156.25	$172K

Holdings After Transaction: Ordinary Shares — 18,545 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Credo Technology Group (CRDO) report on this Form 4?

This Form 4 reports that director Sylvia Acevedo sold a total of 2,200 ordinary shares of Credo Technology Group Holding Ltd on January 13, 2026, in two separate transactions of 1,100 shares each.

At what prices did Sylvia Acevedo sell Credo (CRDO) shares?

Sylvia Acevedo sold 1,100 ordinary shares at $162.11 per share and another 1,100 ordinary shares at $156.25 per share, according to the Form 4.

How many Credo Technology Group (CRDO) shares does Sylvia Acevedo own after the reported sales?

Following the reported transactions, Sylvia Acevedo directly beneficially owned 18,545 ordinary shares of Credo Technology Group Holding Ltd.

What is Sylvia Acevedo’s relationship to Credo Technology Group (CRDO)?

The Form 4 identifies Sylvia Acevedo as a director of Credo Technology Group Holding Ltd and indicates she is not a 10% owner or officer of the company.

Were any derivative securities reported in this Credo (CRDO) Form 4 filing?

No. The Form 4 shows activity only in non-derivative ordinary shares, and no derivative securities are listed in Table II.

Is the Credo (CRDO) Form 4 filed for one or multiple reporting persons?

The filing indicates that it is a Form filed by one reporting person, covering transactions by director Sylvia Acevedo only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ACEVEDO SYLVIA

(Last) (First) (Middle)

110 RIO ROBLES

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Credo Technology Group Holding Ltd [ CRDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/13/2026		S		1,100	D	$162.11	19,645	D
Ordinary Shares	01/13/2026		S		1,100	D	$156.25	18,545	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ James Laufman, attorney-in-fact	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.